Long-term immunogenicity of pandemic influenza vaccine with seasonal influenza vaccination in paediatric patients with type 1 diabetes mellitus

Trial Profile

Long-term immunogenicity of pandemic influenza vaccine with seasonal influenza vaccination in paediatric patients with type 1 diabetes mellitus

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Sep 2011

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
  • Indications Influenza A virus H1N1 subtype; Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Sep 2011 New trial record
    • 14 Sep 2011 Results published in Diabetic Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top